Literature DB >> 25893421

Development and Validation of a Single-Item Screener for Self-Reporting Sexual Problems in U.S. Adults.

Kathryn E Flynn1, Stacy Tessler Lindau2,3, Li Lin4, Jennifer Barsky Reese5, Diana D Jeffery6, Jeanne Carter7, Shirley R Baron8, Emily Abramsohn2, Kevin P Weinfurt4,9.   

Abstract

BACKGROUND: Brief self-assessment of sexual problems in a clinical context has the potential to improve care for patients through the ability to track trends in sexual problems over time and facilitate patient-provider communication about this important topic. However, instruments designed for research are typically too long to be practical in clinical practice.
OBJECTIVE: To develop and validate a single-item self-report clinical screener that would capture common sexual problems and concerns for men and women.
DESIGN: We created three candidate screener items, refined them through cognitive interviews, and administered them to a large sample. We compared the prevalence of responses to each item and explored the discrepancies between items. We evaluated the construct validity of the items by comparing them to scores on the Patient-Reported Outcomes Measurement Information System® Sexual Function and Satisfaction (PROMIS® SexFS) measure. PARTICIPANTS: Local patients participated in two rounds of cognitive interviews (n = 7 and n = 11). A probability-based random sample of U.S. adults comprised the item-testing sample (n = 3517). MAIN MEASURES: The items were as follows: 1) a yes/no item on any sexual problems or concerns ("general screener"), 2) a yes/no item on problems experienced for 3 months or more during the past 12 months, with a list of examples ("long list screener"), and 3) an item identical to the long list screener except that examples appeared individually as response options and respondents could check all that applied ("checklist screener"). KEY
RESULTS: All of the screeners tested showed evidence for basic validity and had minimal missing data. Percentages of women and men endorsing the screeners were 10 % and 15 % (general); 20 % and 17 % (long list); and 38 % and 30 % (checklist), respectively. Participants who endorsed the screeners had lower function compared to those who did not endorse them.
CONCLUSIONS: We recommend the checklist screener for its specificity and ability to identify specific problems associated with decreased sexual function.

Entities:  

Mesh:

Year:  2015        PMID: 25893421      PMCID: PMC4579234          DOI: 10.1007/s11606-015-3333-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  18 in total

1.  The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.

Authors:  R Rosen; C Brown; J Heiman; S Leiblum; C Meston; R Shabsigh; D Ferguson; R D'Agostino
Journal:  J Sex Marital Ther       Date:  2000 Apr-Jun

2.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

Authors:  R C Rosen; A Riley; G Wagner; I H Osterloh; J Kirkpatrick; A Mishra
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

3.  Erectile dysfunctions in patient-physician communication: optimized strategies for addressing sexual issues and the benefit of using a patient questionnaire.

Authors:  Uwe Hartmann; Martin Burkart
Journal:  J Sex Med       Date:  2006-11-06       Impact factor: 3.802

4.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

5.  A study of sexuality and health among older adults in the United States.

Authors:  Stacy Tessler Lindau; L Philip Schumm; Edward O Laumann; Wendy Levinson; Colm A O'Muircheartaigh; Linda J Waite
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

6.  Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs.

Authors:  Amanda J Hordern; Annette F Street
Journal:  Med J Aust       Date:  2007-03-05       Impact factor: 7.738

7.  Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges.

Authors:  Alice K Fortune-Greeley; Kathryn E Flynn; Diana D Jeffery; Megan S Williams; Francis J Keefe; Bryce B Reeve; Gordon B Willis; Kevin P Weinfurt
Journal:  Qual Life Res       Date:  2009-08-12       Impact factor: 4.147

8.  "Opening a can of worms": GP and practice nurse barriers to talking about sexual health in primary care.

Authors:  Merryn Gott; Elisabeth Galena; Sharron Hinchliff; Helen Elford
Journal:  Fam Pract       Date:  2004-10       Impact factor: 2.267

9.  General practitioner attitudes to discussing sexual health issues with older people.

Authors:  Merryn Gott; Sharron Hinchliff; Elisabeth Galena
Journal:  Soc Sci Med       Date:  2004-06       Impact factor: 4.634

10.  Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues.

Authors:  M L Stead; J M Brown; L Fallowfield; P Selby
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

View more
  18 in total

1.  Capsule Commentary on Flynn et al., Development and Validation of a Single-Item Screener for Self-Reporting Sexual Problems in U.S. Adults.

Authors:  Jeffrey L Jackson
Journal:  J Gen Intern Med       Date:  2015-10       Impact factor: 5.128

2.  Gender Differences in Sexual Interest or Activity among Adults with Symptomatic Heart Failure.

Authors:  Stacy Fischer; David Bekelman
Journal:  J Palliat Med       Date:  2017-03-20       Impact factor: 2.947

3.  A manifesto on the preservation of sexual function in women and girls with cancer.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Amber C Matthews
Journal:  Am J Obstet Gynecol       Date:  2015-03-25       Impact factor: 8.661

4.  Cancer negatively impacts on sexual function in adolescents and young adults: The AYA HOPE study.

Authors:  Lena Wettergren; Erin E Kent; Sandra A Mitchell; Brad Zebrack; Charles F Lynch; Mara B Rubenstein; Theresa H M Keegan; Xiao-Cheng Wu; Helen M Parsons; Ashley Wilder Smith
Journal:  Psychooncology       Date:  2016-06-20       Impact factor: 3.894

5.  Patient-clinician communication about sexual health in breast cancer: A mixed-methods analysis of clinic dialogue.

Authors:  Jennifer Barsky Reese; Kristen Sorice; Stephen J Lepore; Mary B Daly; James A Tulsky; Mary Catherine Beach
Journal:  Patient Educ Couns       Date:  2018-10-04

Review 6.  Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Shirley R Baron; Judith Florendo; Hope K Haefner; Anuja Jhingran; Vanessa Kennedy; Mukta K Krane; David M Kushner; Jennifer McComb; Diane F Merritt; Julie E Park; Amy Siston; Margaret Straub; Lauren Streicher
Journal:  CA Cancer J Clin       Date:  2016-01-19       Impact factor: 508.702

Review 7.  Reproductive health care across the lifecourse of the female cancer patient.

Authors:  Lisa A Rubinsak; Mindy S Christianson; Aletha Akers; Jeanne Carter; Andrew M Kaunitz; Sarah M Temkin
Journal:  Support Care Cancer       Date:  2018-07-26       Impact factor: 3.603

Review 8.  Sexual Function in Women with Colorectal/Anal Cancer.

Authors:  Jocelyn Canty; Cara Stabile; Lisania Milli; Barbara Seidel; Deborah Goldfrank; Jeanne Carter
Journal:  Sex Med Rev       Date:  2019-01-14

9.  Sexual Orientation and Patient-Provider Communication About Sexual Problems or Concerns Among US Adults.

Authors:  Kathryn E Flynn; Dane Whicker; Li Lin; Rachel Cusatis; Alan Nyitray; Kevin P Weinfurt
Journal:  J Gen Intern Med       Date:  2019-08-26       Impact factor: 5.128

10.  Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: a longitudinal study.

Authors:  Jennifer Barsky Reese; Elizabeth Handorf; Jennifer A Haythornthwaite
Journal:  Support Care Cancer       Date:  2018-04-20       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.